
ASCO 2020: Immunotherapy following chemotherapy offers extended survival to patients with advanced urothelial cancer
Treatment with avelumab combined with best supportive care following chemotherapy significantly extended overall survival compared…
Treatment with avelumab combined with best supportive care following chemotherapy significantly extended overall survival compared…